Articles of Interest

The Drug Enforcement Administration is warning the public of a widespread fraud scheme in which scammers impersonate DEA agents in an attempt to extort money or steal personal identifiable information. DEA personnel will never contact members of the public or medical practitioners to demand money or any other form of payment, will never request personal or sensitive information, and will only...

This happened to one of our members last week. She received a call from a DEA agent saying that she was under investigation because her DEA, NPI, and License # were involved in the trafficking of narcotics. Large packages of methadone, hydrocodone, suboxone, and other narcotics arrived in Texas under her DEA #. The agents gave her their names and badge numbers. They started by talking...

Synopsis: The importance of responsibly expanding access to methadone treatment for opioid use disorder (OUD) is crucial. Methadone, a long-lasting opioid agonist, is a well-studied and effective medical treatment for OUD, which is associated with a significantly higher risk of early death. While there is support for liberalizing access to methadone from opioid treatment programs...

On May 10th, national organizations, including the American Society of Addiction Medicine, the American College of Emergency Physicians, the American Psychological Association, the American Psychiatric Association, and Faces & Voices of Recovery, held a briefing for the 118th Congress, and strongly encouraged a national response to the deadly substance use and addiction crisis...

Today, the Centers for Medicare & Medicaid Services (CMS) issued a letter to State Medicaid Directors announcing a new opportunity for states to help increase care for individuals who are incarcerated in the period immediately prior to their release. The new Medicaid Reentry Section 1115 Demonstration Opportunity will allow state Medicaid programs to cover a package of pre-release...

Please give to help us spread awareness, to remember Tennesseans lost to addiction, to provide support to families, to spread the message of harm reduction, to provide hope of recovery and to work together with all addiction causes. We will be using these donations for billboards across Tennessee. Please fill out this photo release form if you are submitting a photo...

Hi Chapter Presidents – Hope all is well. US Senators Markey and Paul (as well as their House counterparts) plan to introduce – soon – the portions of the Opioid Treatment Access Act (OTAA) from the last Congress that didn’t make it into the Consolidated Appropriations Act, 2023. Attached is that draft legislation. In brief, this legislation, now named the “Modernizing Opioid...

Good Morning, ASAM Chapter Presidents and Advocacy Leaders: SAMHSA has recently posted the following message on its website: Congress has taken action in the recent Consolidated Appropriations Act, 2023 that impacts federal requirements for Drug Enforcement Administration (DEA) registrants, including those involved in OUD treatment. SAMHSA and DEA are actively working to develop further...

Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD). With this provision, and effective immediately, SAMHSA will no longer be accepting NOIs (waiver applications). All...

Good Evening – I bring good news. One thing ASAM was not able to achieve – which had been on our legislative agenda – during our Addiction Medicine Advocacy Conference last year – was the passage of the Medicaid Reentry Act, which would have allowed for Medicaid coverage for eligible individuals – who were incarcerated – up to 30 days prior to their release....

The Drug Enforcement Administration is Warning the Public of a Widespread Fraud Scheme

GSAM SCAM ALERT: SCAMMERS POSE AS DEA AGENTS

The Modernizing Opioid Treatment Access Act: A Helpful Explanation

Congressional Briefing, Expert Panel Suggests Innovative Solutions to National Addiction Crisis

CMS Issues Letter to State Medicaid Directors to Improve Care Transitions for Incarcerated Individuals

Fentanyl Kills Billboard Campaign: Your Support Fosters Awareness and Change

Legislative Draft for the Consolidated Appropriations Act, 2023

Congress Takes Action Which Impacts Federal Requirements for DEA Registrants

NEW SAMHSA MESSAGE ON CONSOLIDATED APPROPRIATIONS ACT, 2023

Critical Pre-release Services for Incarcerated Individuals

The Georgia Society of Addiction Medicine